What other stocks do shareholders of Mach7 Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mach7 Technologies investors own include MicroVision (MVIS) , Genex Power (GNX) , Corning (GLW) and Denali Therapeutics (DNLI) .

ASX:M7T

Mach7 Technologies (M7T) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free M7T Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 272,627 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 3.37%
Price Target: N/A

Stock Analysis

Get Mach7 Technologies alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Mach7 Technologies

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing, which includes eUnity zero-footprint viewer that connects departmental imaging from across the enterprise to deliver studies to care providers via the EMR. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

M7T Stock News Headlines

June 2, 2023 | fool.com

Semler Scientific (NASDAQ: SMLR)

May 23, 2023 | fool.com

Bioventus (NASDAQ: BVS)

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

May 5, 2023 | finance.yahoo.com

Mach7 Technologies Limited's (ASX:M7T) Popularity With Investors Is Under Threat From Overpricing

April 19, 2023 | finance.yahoo.com

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

April 5, 2023 | finance.yahoo.com

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

March 1, 2023 | finance.yahoo.com

Mach7 Technologies First Half 2023 Earnings: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2022)

February 23, 2023 | finance.yahoo.com

Mach7 Technologies Limited (ASX:M7T) is definitely on the radar of institutional investors who own 50% of the company

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 6, 2023 | finance.yahoo.com

Mach7 Technologies (ASX:M7T) delivers shareholders stellar 23% CAGR over 5 years, surging 18% in the last week alone

January 2, 2023 | msn.com

Mach7 signs $17 million contract – share price jumps 20% at open

November 1, 2022 | finance.yahoo.com

Mach7 Technologies and Nuvodia Partner to Deliver Industry Differentiated Healthcare Informatics Solutions

October 27, 2022 | finance.yahoo.com

Mach7 Technologies Limited's (ASX:M7T) Intrinsic Value Is Potentially 86% Above Its Share Price

July 10, 2022 | finance.yahoo.com

Mach7 Technologies (ASX:M7T) shareholders have earned a 25% CAGR over the last five years

June 10, 2022 | finance.yahoo.com

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

May 21, 2022 | news.yahoo.com

First Brightline train arrives at Orlando International Airport stop

May 21, 2022 | yahoo.com

Epic Game Store sale includes huge discounts for 'Final Fantasy' and 'Far Cry'

May 20, 2022 | nz.finance.yahoo.com

Vietnam Blockchain Association Affirmed Their Objectives And Missions In Industry 4.0

March 15, 2022 | finance.yahoo.com

Mach7 Technologies partners with Bialogics to deliver analytics and operational insights within its Enterprise Imaging Solution

March 8, 2022 | finance.yahoo.com

Mach7 Technologies Limited (M7T.AX)

January 10, 2022 | finance.yahoo.com

Investors in Mach7 Technologies (ASX:M7T) have made a incredible return of 305% over the past three years

November 10, 2021 | finance.yahoo.com

Mach7 Technologies Limited (ASX:M7T) Shares Could Be 47% Below Their Intrinsic Value Estimate

October 13, 2021 | finance.yahoo.com

Mach7 Technologies Announces Successful Go-Live at Sentara Martha Jefferson Hospital

September 27, 2021 | msn.com

Why the Mach7 (ASX:M7T) share price is roaring 6% higher today

August 23, 2021 | msn.com

Mach7 (ASX:M7T) share price slides on mixed FY21 result

July 27, 2021 | finance.yahoo.com

Mach7 Technologies Receives Multiple 2021 Industry Awards

July 22, 2021 | investing.com

Mach7 Technologies Ltd (M7T)

See More Headlines

Receive M7T Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mach7 Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: ASX:M7T
CUSIP: N/A
CIK: N/A
Web: www.mach7t.com
Phone: 802-861-7745
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: -23.2
Net Income: $-5,550,000.00
Net Margins: -20.58%
Pretax Margin: N/A
Return on Equity: -9.94%
Return on Assets: -9.63%

Debt

Debt-to-Equity Ratio: 1.96
Current Ratio: 2.52
Quick Ratio: 3.05

Sales & Book Value

Annual Sales: $26.98 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 4.17
Book Value: A$0.23 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 241,240,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.62

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Michael Lampron
CEO, MD & Director
Ms. Dyan O'Herne
Chief Financial Officer
Mr. David Madaffri
Chief Operating Officer
Francoise Dixon
Head of Investor Relations
Mr. Bob Tranchida
Vice President of Marketing
Mr. Anthony Panther A.C.I.S.
ACIS, AGIA, B. Ec, B.E., C.A., CA, FDN, Company Secretary

Key Competitors

View All Competitors

Insiders

M7T Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Mach7 Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Mach7 Technologies investors own include MicroVision (MVIS), Genex Power (GNX), Corning (GLW) and Denali Therapeutics (DNLI).

This page (ASX:M7T) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial